share_log

Veriti Management LLC Has $336,000 Holdings in Align Technology, Inc. (NASDAQ:ALGN)

Veriti Management LLC Has $336,000 Holdings in Align Technology, Inc. (NASDAQ:ALGN)

Veriti Management LLC持有Align技術公司336,000美元的股份(納斯達克代碼:ALGN)
Defense World ·  2022/09/29 06:31

Veriti Management LLC increased its stake in shares of Align Technology, Inc. (NASDAQ:ALGN – Get Rating) by 11.1% during the second quarter, according to the company in its most recent filing with the SEC. The fund owned 1,420 shares of the medical equipment provider's stock after acquiring an additional 142 shares during the period. Veriti Management LLC's holdings in Align Technology were worth $336,000 as of its most recent filing with the SEC.

據Align Management LLC在最近提交給美國證券交易委員會的文件中稱,該公司在第二季度增持了Align Technology,Inc.的股票11.1%。該基金持有這家醫療設備提供商1,420股股票,在此期間又購買了142股。截至最近向美國證券交易委員會提交的文件,Veriti Management LLC持有的Align Technology股份價值33.6萬美元。

A number of other institutional investors have also made changes to their positions in the stock. LPL Financial LLC lifted its stake in shares of Align Technology by 4.4% in the fourth quarter. LPL Financial LLC now owns 17,654 shares of the medical equipment provider's stock worth $11,602,000 after buying an additional 736 shares during the last quarter. Eaton Vance Management boosted its holdings in Align Technology by 2.0% during the fourth quarter. Eaton Vance Management now owns 27,592 shares of the medical equipment provider's stock valued at $17,276,000 after acquiring an additional 554 shares during the period. Commerce Bank grew its position in shares of Align Technology by 1.1% in the fourth quarter. Commerce Bank now owns 5,192 shares of the medical equipment provider's stock valued at $3,412,000 after purchasing an additional 54 shares during the last quarter. Guggenheim Capital LLC increased its stake in shares of Align Technology by 16.7% in the fourth quarter. Guggenheim Capital LLC now owns 30,417 shares of the medical equipment provider's stock worth $19,989,000 after purchasing an additional 4,347 shares during the period. Finally, PDT Partners LLC acquired a new position in shares of Align Technology during the 4th quarter worth about $657,000. 86.50% of the stock is owned by institutional investors.

其他一些機構投資者也改變了他們在該股的頭寸。LPL Financial LLC在第四季度增持了Align Technology 4.4%的股份。LPL Financial LLC現在擁有這家醫療設備提供商17,654股股票,價值11,602,000美元,上個季度又購買了736股。伊頓·萬斯管理公司在第四季度將其在Align Technology的持股增加了2.0%。伊頓·萬斯管理公司在此期間額外收購了554股,現在擁有27,592股這家醫療設備提供商的股票,價值17,276,000美元。商業銀行在第四季度將其在Align Technology的股票頭寸增加了1.1%。商業銀行現在擁有這家醫療設備提供商5,192股股票,價值3,412,000美元,上個季度又購買了54股。古根海姆資本有限責任公司在第四季度增持了Align Technology的股份16.7%。古根海姆資本有限責任公司現在擁有這家醫療設備提供商30,417股股票,價值19,989,000美元,在此期間又購買了4,347股。最後,PDT Partners LLC在第四季度收購了Align Technology的新頭寸,價值約65.7萬美元。86.50%的股份由機構投資者持有。

Get
到達
Align Technology
Align技術
alerts:
警報:

Align Technology Trading Down 1.0 %

Align技術交易下跌1.0%

Shares of ALGN opened at $212.10 on Thursday. The stock has a market cap of $16.57 billion, a PE ratio of 27.12, a PEG ratio of 6.58 and a beta of 1.80. Align Technology, Inc. has a 1 year low of $206.67 and a 1 year high of $713.33. The stock has a 50 day simple moving average of $259.66 and a 200-day simple moving average of $298.51.

週四,algn的股價開盤報212.10美元。該股市值為165.7億美元,市盈率為27.12倍,市盈率為6.58倍,貝塔係數為1.80倍。Align Technology,Inc.的一年低點為206.67美元,一年高位為713.33美元。該股的50日簡單移動均線切入位為259.66美元,200日簡單移動均線切入位為298.51美元。

Align Technology (NASDAQ:ALGN – Get Rating) last issued its quarterly earnings data on Wednesday, July 27th. The medical equipment provider reported $1.57 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.79 by ($0.22). Align Technology had a net margin of 15.52% and a return on equity of 17.47%. The company had revenue of $969.60 million for the quarter, compared to the consensus estimate of $986.05 million. During the same period in the previous year, the business posted $2.51 earnings per share. The firm's revenue was down 3.0% compared to the same quarter last year. On average, sell-side analysts forecast that Align Technology, Inc. will post 7.73 EPS for the current fiscal year.
Align科技(納斯達克代碼:ALGN-GET Rating)上一次發佈季度收益數據是在7月27日星期三。這家醫療設備供應商公佈本季度每股收益(EPS)為1.57美元,低於分析師普遍預期的1.79美元(0.22美元)。Align Technology的淨利潤率為15.52%,股本回報率為17.47%。該公司本季度營收為9.696億美元,而市場普遍預期為9.8605億美元。去年同期,該業務公佈的每股收益為2.51美元。與去年同期相比,該公司的收入下降了3.0%。賣方分析師平均預測Align Technology,Inc.本財年每股收益為7.73歐元。

Analyst Ratings Changes

分析師評級發生變化

ALGN has been the topic of several recent analyst reports. UBS Group dropped their price target on Align Technology from $380.00 to $370.00 and set a "buy" rating on the stock in a research report on Friday, July 29th. Morgan Stanley reduced their price target on shares of Align Technology from $438.00 to $402.00 and set an "overweight" rating for the company in a report on Thursday, July 28th. Robert W. Baird dropped their price objective on shares of Align Technology from $450.00 to $410.00 and set an "outperform" rating on the stock in a report on Thursday, July 28th. Evercore ISI reduced their target price on shares of Align Technology from $310.00 to $285.00 in a research note on Thursday, July 28th. Finally, Stifel Nicolaus lowered their price target on Align Technology from $425.00 to $375.00 and set a "buy" rating on the stock in a research note on Thursday, July 14th. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and eight have issued a buy rating to the company's stock. According to MarketBeat.com, Align Technology currently has a consensus rating of "Moderate Buy" and a consensus target price of $358.33.

ALGN一直是最近幾份分析師報告的主題。7月29日,瑞銀集團在一份研究報告中將Align Technology的目標價從380.00美元下調至370.00美元,並對該股設定了“買入”評級。摩根士丹利在7月28日週四的一份報告中將Align科技的股票目標價從438.00美元下調至402.00美元,並對該公司設定了“增持”評級。羅伯特·W·貝爾德在7月28日週四的一份報告中將Align科技公司的股票目標價從450.00美元下調至410.00美元,並對該股設定了“跑贏大盤”的評級。7月28日,Evercore ISI在一份研究報告中將Align科技的目標股價從310.00美元下調至285.00美元。最後,斯蒂菲爾·尼古拉斯將Align Technology的目標價從425.00美元下調至375.00美元,並在14日(星期四)的一份研究報告中對該股設定了“買入”評級。一位研究分析師對該股的評級為賣出,一位分析師給出了持有評級,八位分析師給出了該公司股票的買入評級。根據MarketBeat.com的數據,Align Technology目前的共識評級為“適度買入”,共識目標價為358.33美元。

Align Technology Profile

調整技術概況

(Get Rating)

(獲取評級)

Align Technology, Inc, a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services.

Align Technology,Inc.是一家醫療設備公司,設計、製造和銷售InvisAlign Clear Aligers和iTero口腔內掃描儀,併為正畸醫生和全科醫生牙醫以及修復和美容牙科提供服務。它分為兩個部分,Clear Aligner;以及掃描儀和服務。

See Also

另請參閲

  • Get a free copy of the StockNews.com research report on Align Technology (ALGN)
  • A Trio of Q3 Winners With Room to Run
  • This Little Known Small Cap Is Up 139%: Is The Stock A Buy?
  • Can HCA Healthcare Weather the Normalization?
  • Can United Natural Foods Fight Both Inflation and the Fed?
  • Mullen Automotive Is Ready To Get In Gear
  • 免費獲取StockNews.com關於Align技術(ALGN)的研究報告
  • 第三季度贏家三人組還有運行的空間
  • 這個小知名的小盤股上漲了139%:這隻股票是買入的嗎?
  • HCA醫療能否經受住正常化的考驗?
  • 聯合天然食品能同時對抗通脹和美聯儲嗎?
  • 馬倫汽車已做好準備投入使用

Want to see what other hedge funds are holding ALGN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Align Technology, Inc. (NASDAQ:ALGN – Get Rating).

想看看還有哪些對衝基金持有ALGN嗎?訪問HoldingsChannel.com獲取Align科技公司(納斯達克代碼:ALGN-GET Rating)的最新13F備案文件和內幕交易信息。

Receive News & Ratings for Align Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Align Technology and related companies with MarketBeat.com's FREE daily email newsletter.

接受Align技術日報的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對Align科技和相關公司的最新新聞和分析師評級的每日簡要摘要。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論